Delivery Order SPE2DB22D3004-SPE2DB25FSF74
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,086.82 by the Defense Logistics Agency on August 7, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL injectable medication. The contract carries a firm fixed price structure with no set-aside designation, indicating the award was made through open competitive procurement. Performance is scheduled for completion by August 8, 2025, with...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,917.35 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone therapeutic product. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,604.02 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,836.65 by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, for the supply of Norditropin Flexpro 10 mg/1.5 ml. This is a non-set-aside, competitively awarded contract with firm fixed pricing, with an ultimate completion date of August 29, 2025. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen...
- The Defense Logistics Agency awarded a $4,198.91 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL medication, with performance to be completed by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,259.34 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open...
- The Defense Logistics Agency awarded a $4,190.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product, with an ultimate completion date of August 8, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,283.33 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,396.92 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product. This firm fixed-price delivery order, issued on July 24, 2025, represents a non-competitive set-aside award and is scheduled for completion by July 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,837.70 order is for the supply of Norditropin FlexPro 10 mg/1.5 medication, with a completion date of February 16, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as a prime contractor...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSF74Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $1,629.67 by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL injectable medication. The contract, which carries no set-aside designation, is scheduled for completion by September 2, 2025, with performance taking place at the vendor's Conshohocken facility. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery/Indefinite Quantity (IDIQ) agreement with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The award reflects AmerisourceBergen's established role as a critical federal medical procurement vendor, particularly within the Defense Health System. Norditropin, a human growth hormone therapeutic, is a specialty pharmaceutical product consistent with the company's portfolio of brand-name medications and specialized healthcare commodities serving military and veteran healthcare systems. As a competitively awarded, non-set-aside contract with firm fixed pricing, this delivery order demonstrates the vendor's capability to meet federal procurement requirements through open competition while fulfilling specific pharmaceutical supply needs within the DLA Troop Support Medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/29/25 |